GSK signed a 12-asset licensing deal with Hengrui Pharma. Generic erosion on Vyvanse continued to hurt Takeda. Celltrion is ...

Symphony Limited announced its financial results for the quarter ending June 2025, reporting a 36% year-on-year decline in ...

By the end of 2024, Axmed had partnered with over 20 organizations across 15 countries. It processed more than 4,200 orders, ...

In the aftermath of the 1971 Liberation War, newly sovereign Bangladesh inherited little industrial infrastructure.

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

European pharmaceutical stocks slumped, continuing a selloff that started with US-listed peers after President Donald Trump escalated his campaign to pressure drugmakers to lower prices in the country ...

The FTSE 100 sank on Friday after US President Donald Trump announced tariffs on dozens of trading partners, and weak US jobs ...

News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, Tax Shelters, Insurance bonds. Investors brace for impact as Trump confirms 7 ...

President Donald Trump escalated his campaign to pressure pharmaceutical companies to lower drug prices, sending letters to 17 of the world’s largest drugmakers demanding they charge the U.S. what oth ...

The Bureau of Labour Statistics reported earlier on Friday that the US had added 73,000 jobs in July, far lower than expected ...

London stocks were still in the red by midday on Friday as investors mulled US President Trump’s sweeping new tariffs and ...

The FTSE 100 sank on Friday after US President Donald Trump announced tariffs on dozens of trading partners, and weak US jobs data fuelled concerns as to the strength of the US economy. The FTSE 100 ...